| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/10/2007 | US7241735 conjugates of substantially pure specific polypeptides and specific polysaccharides; has activity in inhibiting the production of tumor necrosis factor (TNF) in a patient when an effective amount of the glycoconjugate is administered |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241606 α-Isomaltosylglucosaccharide synthase, process for producing the same and use thereof |
| 07/10/2007 | US7241595 Preparation of antiproliferative agent; obtain chemical intermediates, insert into reaction mixture, heat, remove protective groups, recover antiproliferative agent |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | US7241460 Strontium compound for treatment of sub-dermal soft tissue pain |
| 07/10/2007 | US7241458 Antiviral compositions |
| 07/10/2007 | US7241456 Formulations for topical delivery of bioactive substances and methods for their use |
| 07/10/2007 | US7241455 Implantable or insertable medical devices containing radiation-crosslinked polymer for controlled delivery of a therapeutic agent |
| 07/10/2007 | US7241444 Anti-IGF-IR antibodies and uses thereof |
| 07/10/2007 | US7240785 Method and apparatus for transferring substrates |
| 07/10/2007 | CA2441461C Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia |
| 07/10/2007 | CA2370853C Compositions for aerosolization and inhalation |
| 07/10/2007 | CA2270024C Highly soluble, hydratable, viscous, solution stable pyrodextrins, process of making and use thereof |
| 07/10/2007 | CA2238313C Thermolabile uracil-dna-glycosylase, process for its production and use for removing uracil from dna |
| 07/10/2007 | CA2173316C Local polymeric gel cellular therapy |
| 07/10/2007 | CA2095776C Rapidly dispersable compositions containing polydextrose |
| 07/05/2007 | WO2007076448A2 Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 07/05/2007 | WO2007076295A2 Nanoclusters for delivery of therapeutics |
| 07/05/2007 | WO2007075534A2 Polymer conjugates of glp-1 |
| 07/05/2007 | WO2007074996A1 Stable pharmaceutical composition containing s-omeprazole and a method of manufacturing the same |
| 07/05/2007 | WO2007074910A1 Controlled release solid preparation |
| 07/05/2007 | WO2007074909A1 Controlled release solid preparation |
| 07/05/2007 | WO2007074904A1 Aqueous pharmaceutical composition |
| 07/05/2007 | WO2007074880A1 Antibody-containing stabilizing preparation |
| 07/05/2007 | WO2007074856A1 Method of producing solid preparation disintegrating in the oral cavity |
| 07/05/2007 | WO2007074641A1 Pharmaceutical preparation of aqueous solution containing platinum complex |
| 07/05/2007 | WO2007074604A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance |
| 07/05/2007 | WO2007073782A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | WO2007073682A1 Dropping pill of butylbenzene phthalein and its application |
| 07/05/2007 | WO2007073596A1 Degradable polymeric microsphere composition |
| 07/05/2007 | WO2007054182A3 Nanoparticles used as contrasting agents in magnetic resonance imaging |
| 07/05/2007 | WO2007027560A3 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 07/05/2007 | WO2007024536A3 Process for preparing maytansinoid antibody conjugates |
| 07/05/2007 | WO2007023495A3 Method for production of single- and multi-layer microcapsules |
| 07/05/2007 | WO2007008566A3 Inorganic shell-based radionuclide nanoparticles bound to biomolecules |
| 07/05/2007 | US20070155780 Stabilized composition containing 4-amino-5-chloro-n-[(1r, 3r, 5s)-8-methyl-8-azabicyclo[3.2.1]oct-3-y1]-2-[1-methylbut-2-ynyloxy]benzamide |
| 07/05/2007 | US20070155768 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 07/05/2007 | US20070155697 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms |
| 07/05/2007 | US20070155658 Complexed via melamine derivative and optionally polyarginine or a polymer of glutamine and asparagine; RNA interference |
| 07/05/2007 | US20070155654 Novel formulations |
| 07/05/2007 | US20070155653 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.2% by weight of zinc based on the insulin content of the formulation; Polypeptide mixture containing preservative, surfactant and stabilizer |
| 07/05/2007 | US20070154577 Herbal compositions inhibiting free radicals |
| 07/05/2007 | US20070154559 comprising 0.1-30 weight % complex of water-soluble drug and counter-ion substance in which charged water-soluble drug is bonded with counter-ion substance, 0.5-80 weight % lipid, 0.5-80 weight % polymer, and 1-80 weight % emulsifier; high gastrointestinal absorption rate; high drug entrapping rate |
| 07/05/2007 | US20070154541 Seamless capsule containing water-soluble active substance |
| 07/05/2007 | US20070154532 Compositions comprising vitamins and/or derivatives thereof stablished with olea europea extract and/or ionene polymers |
| 07/05/2007 | US20070154526 Ingestible carrier for medications and structure and method for making |
| 07/05/2007 | US20070154497 Stable, palatable syrup containing ibuprofen and method of its preparation |
| 07/05/2007 | US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 07/05/2007 | US20070154447 Linear polyethylenimine-sterol conjugates for gene delivery |
| 07/05/2007 | US20070154437 Peptide-tagged proteins and methods of making and using thereof |
| 07/05/2007 | US20070154401 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154400 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154396 Block copolymers and nano micelles comprising the same |
| 07/05/2007 | US20070151569 Methods for achieving and maintaining weight loss |
| 07/05/2007 | DE102005062440A1 Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen Protein-based carrier system to overcome resistance of tumor cells |
| 07/05/2007 | CA2836123A1 Compositions and methods for producing a composition |
| 07/05/2007 | CA2635575A1 Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof |
| 07/05/2007 | CA2635375A1 Synergistic effect between a cyanogenic system and another oxidative inducer for the treatment of tumours |
| 07/05/2007 | CA2634969A1 Controlled release solid preparation |
| 07/05/2007 | CA2634830A1 Degradable polymeric microsphere composition |
| 07/05/2007 | CA2634637A1 Controlled release solid preparation |
| 07/05/2007 | CA2634232A1 Method of producing solid preparation disintegrating in the oral cavity |
| 07/05/2007 | CA2634131A1 Protein formulations with reduced viscosity and uses thereof |
| 07/05/2007 | CA2633655A1 Topical mecamylamine formulations for ocular administration and uses therof |
| 07/05/2007 | CA2633380A1 Nanoclusters for delivery of therapeutics |
| 07/05/2007 | CA2633356A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | CA2633070A1 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 07/04/2007 | EP1803808A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803467A1 Composite fine particles and process for producing the same |
| 07/04/2007 | EP1803464A1 External preparation for treating skin ulcer |
| 07/04/2007 | EP1803459A1 Antitumor composition |
| 07/04/2007 | EP1803449A2 Modified release formulation of lithium carbonate and method for the preparation thereof |
| 07/04/2007 | EP1803448A2 Tasted masked veterinary solid compositions |
| 07/04/2007 | EP1803446A1 Orally disintegrating tablet and method of preparation |
| 07/04/2007 | EP1803445A2 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/04/2007 | EP1802349A1 Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle |
| 07/04/2007 | EP1802348A2 Complex containing mequitazine, a cyclodextrin and an interaction agent |
| 07/04/2007 | EP1802347A1 Anti-snoring composition |
| 07/04/2007 | EP1802346A1 Sustained release pharmaceutical composition |
| 07/04/2007 | EP1802333A2 Antibody buffering of a ligand in vivo |
| 07/04/2007 | EP1802317A2 Use of a2a adenosine receptor agonists |
| 07/04/2007 | EP1802309A2 Method and composition for supplementation of nutritional deficiencies in renal patients |
| 07/04/2007 | EP1802295A1 Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof |
| 07/04/2007 | EP1802282A1 Biocompatible protein particles, particle devices and methods thereof |
| 07/04/2007 | EP1802203A1 Animal feedstuff dyeing and animal drugs |
| 07/04/2007 | EP1392751B1 Biodegradable copolymers linked to segment with a plurality of functional groups |
| 07/04/2007 | EP1331972B1 Pharmaceutical compositions |
| 07/04/2007 | EP1203590B1 Solid preparations containing chitosan powder and process for producing the same |
| 07/04/2007 | EP1053023B1 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 07/04/2007 | EP0868435B1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 07/04/2007 | EP0713399B1 Method for binding to polymers |
| 07/04/2007 | EP0567566B2 Methods for treating tumor necrosis factor mediated diseases |
| 07/04/2007 | CN1993380A Ultrasound-assisted synthesis of cyclodextrin-based nanosponges |
| 07/04/2007 | CN1993146A Antibody-drug conjugates and methods |
| 07/04/2007 | CN1993145A Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances |
| 07/04/2007 | CN1993144A Stable dosing form of phenylalanine derivatives |
| 07/04/2007 | CN1993141A Induction of an immune response against streptococcus pneumoniae polysaccharides |
| 07/04/2007 | CN1993138A Method of stabilizing proteins |